Elon Musk Set to Test Brain Chips with his Start-Up Neuralink

Here’s how Elon Musk will obtain a brain chip and plans to test it on humans soon

Elon Musk, a tech billionaire, claimed that one of his businesses would be able to implant a device into a person's brain that would enable communication with a computer in six months. The interface developed by his start-up Neuralink would enable users to communicate with computers directly through their thoughts.

Elon Musk stated that he intends to buy one of the chips personally. In a company presentation, he stated, "We've submitted, I believe, most of our paperwork to the FDA (US Food and Drug Administration) and we think probably in about six months we should be able to have our first Neuralink in a human." To be prepared for our first human implant, he said, "We've been working hard, and we want to be extremely careful and certain that it will work well before putting a device in a human." Musk, who recently acquired Twitter in addition to owning SpaceX, Tesla, and several other businesses, is known for making ambitious predictions about his businesses, many of which have not come to pass.

He promised in July 2019 that Neuralink would be able to conduct its first human tests in 2020. The monkeys' skulls have been implanted with the prototypes, which are the size of coins. During the Neuralink presentation, the company displayed several monkeys using their Neuralink implants to "play" simple video games or move a cursor on a screen. Musk stated that the business would try to use the implants to help people regain their vision and mobility. In the beginning, he explained, "we would enable someone who has almost no ability to operate their muscles and enable them to operate their phone faster than someone who has working hands." We are confident that it is possible to restore full body functionality to someone who has had their spinal cord severed, despite how miraculous it may sound.

Musk said his ultimate goal is to prevent humans from being intellectually overpowered by artificial intelligence, which goes beyond the potential to treat neurological diseases. Synchron, which declared in July that it had implanted the first brain-machine interface in the United States, is one of the companies working on comparable systems.